{
  "retracted": false,
  "timestamp": 1480464000000,
  "updates": [
    {
      "timestamp": 1578030212123,
      "identifier": {
        "doi": "10.1186/s13045-016-0364-0"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1186/s13045-015-0215-4"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Childrenâ€™s Oncology Group"
}
